Results 151 to 160 of about 13,707 (310)

Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

Exploration of Asthma & Allergy
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory disease of the mucous membranes of the nose and paranasal sinuses. Eosinophilic inflammation is described as a common endotype.
L. Klimek, U. Förster-Ruhrmann, Heidi Olze, Achim G. Beule, A. Chaker, J. Hagemann, T. Huppertz, T. K. Hoffmann, S. Dazert, T. Deitmer, Sebastian Strieth, H. Wrede, Wolfgang W. Schlenter, Hans-Jürgen Welkoborsky, B. Wollenberg, Sven Becker, F. Bärhold, F. Klimek, I. Casper, J. Zuberbier, Claudia Rudack, M. Cuevas, Constantin A. Hintschich, Orlando Guntinas-Lichius, Timo Stöver, C. Bergmann, Pascal Werminghaus, O. Pfaar, Jan Gosepath, M. Gröger, C. Beutner, Martin Laudien, Rainer K. Weber, Tanja Hildenbrand, A. Hoffmann, C. Bachert   +35 more
semanticscholar   +1 more source

Bronchial thermoplasty: implementing best practice in the era of cost containment. [PDF]

, 2017
Increasing dependence on advanced technologies in the 21st century has created a dilemma between the practice and business of medicine. From information technology to robotic surgery, new technologies have expanded treatment possibilities and have ...
Kenyon, Nicholas, Louie, Samuel, Tan, Laren D, Yoneda, Ken Y   +3 more
core  

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma [PDF]

, 2011

openalex   +1 more source

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience [PDF]

, 2016
Gilda Varricchi, Diego Bagnasco, Matteo Ferrando, Francesca Puggioni, Giovanni Passalacqua, Giorgio Walter Canonica   +5 more
openalex   +1 more source

Anti-IL-5 treatment (mepolizumab) reduces eosinophil-associated TGF-$beta;*1Relationship to deposition of extracellular matrix proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

, 2004
Patrick Flood-Page, Andrew Menzies‐Gow, Simon Phipps, Sun Ying, A Wangoo, Michelle Ludwig, N. Barnes, David S. Robinson, A.B. Kay   +8 more
openalex   +1 more source

Mepolizumab For The Treatment of Chronic Asthma. A Meta-Analysis of Randomized Placebo-Controlled Trials [PDF]

, 2016
Raju Kanukula, N Likhar, Amit Dang
openalex   +1 more source

S4 Implications of guidance in scotland on eligibility for treatment with mepolizumab and omalizumab – an ideal study analysis [PDF]

, 2016
CEA Hartmann, C Gait, NB Gunsoy, RA Mehta, FC Albers   +4 more
openalex   +1 more source

P14 Therapeutic benefit of mepolizumab in the national institute of health and care excellence (nice) sub-population– a post-hoc meta-analysis of phase iib/iii trials [PDF]

, 2017
H Marwaha, CEA Hartmann, RA Mehta, NB Gunsoy, FC Albers   +4 more
openalex   +1 more source

Care pathways for the selection of a biologic in severe asthma [PDF]

, 2017
Bousquet, Jean, Brusselle, Guy, Buhl, Roland, Busse, William W, Cruz, Alvaro A, Djukanovic, Ratko, Domingo, Christian, Gow, Andrew Menzies, Hanania, Nicola A, Humbert, Marc, Phipatanakul, Wanda, Wahn, Ulrich, Wechsler, Michael E   +12 more
core   +2 more sources

Characteristics of Asthmatic Responders to Mepolizumab after Failed Response to Omalizumab [PDF]

, 2018
Geetika Sabharwal, Faoud T. Ishmael
openalex   +1 more source